Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes.
Jimenez-Leon MR, Gasca-Capote C, Tarancon-Diez L, Dominguez-Molina B, Lopez-Verdugo M, Ritraj R, Gallego I, Alvarez-Rios AI, Vitalle J, Bachiller S, Camacho-Sojo MI, Perez-Gomez A, Espinosa N, Roca-Oporto C, Rafii-El-Idrissi Benhnia M, Gutierrez-Valencia A, Lopez-Cortes LF, Ruiz-Mateos E. Jimenez-Leon MR, et al. Among authors: ruiz mateos e. EBioMedicine. 2023 May;91:104549. doi: 10.1016/j.ebiom.2023.104549. Epub 2023 Apr 3. EBioMedicine. 2023. PMID: 37018973 Free PMC article.
Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.
Gibson RM, Meyer AM, Winner D, Archer J, Feyertag F, Ruiz-Mateos E, Leal M, Robertson DL, Schmotzer CL, Quiñones-Mateu ME. Gibson RM, et al. Antimicrob Agents Chemother. 2014;58(4):2167-85. doi: 10.1128/AAC.02710-13. Epub 2014 Jan 27. Antimicrob Agents Chemother. 2014. PMID: 24468782 Free PMC article.
Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy.
de la Rosa R, Ruíz-Mateos E, Rubio A, Abad MA, Vallejo A, Rivero L, Genebat M, Sánchez-Quijano A, Lissen E, Leal M. de la Rosa R, et al. J Antimicrob Chemother. 2004 Jan;53(1):95-101. doi: 10.1093/jac/dkh012. Epub 2003 Dec 4. J Antimicrob Chemother. 2004. PMID: 14657091 Clinical Trial.
CD27 and CCR7 expression on naive T cells, are both necessary?
Ferrando-Martinez S, Ruiz-Mateos E, Leal M. Ferrando-Martinez S, et al. Immunol Lett. 2010 Jan 4;127(2):157-8. doi: 10.1016/j.imlet.2009.10.001. Epub 2009 Oct 23. Immunol Lett. 2010. PMID: 19854218 No abstract available.
Effect of maraviroc on HIV disease progression-related biomarkers.
Romero-Sánchez MC, Machmach K, Gonzalez-Serna A, Genebat M, Pulido I, García-García M, Alvarez-Ríos AI, Ferrando-Martinez S, Ruiz-Mateos E, Leal M. Romero-Sánchez MC, et al. Antimicrob Agents Chemother. 2012 Nov;56(11):5858-64. doi: 10.1128/AAC.01406-12. Epub 2012 Sep 4. Antimicrob Agents Chemother. 2012. PMID: 22948867 Free PMC article.
133 results